131 related articles for article (PubMed ID: 17692281)
1. Differential mitotic activation of endogenous c-Src, c-Yes, and Lyn in HeLa cells.
Kuga T; Nakayama Y; Hoshino M; Higashiyama Y; Obata Y; Matsuda D; Kasahara K; Fukumoto Y; Yamaguchi N
Arch Biochem Biophys; 2007 Oct; 466(1):116-24. PubMed ID: 17692281
[TBL] [Abstract][Full Text] [Related]
2. Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.
Sato I; Obata Y; Kasahara K; Nakayama Y; Fukumoto Y; Yamasaki T; Yokoyama KK; Saito T; Yamaguchi N
J Cell Sci; 2009 Apr; 122(Pt 7):965-75. PubMed ID: 19258394
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
4. c-Yes tyrosine kinase activity in human colon carcinoma.
Park J; Meisler AI; Cartwright CA
Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases.
Han NM; Curley SA; Gallick GE
Clin Cancer Res; 1996 Aug; 2(8):1397-404. PubMed ID: 9816313
[TBL] [Abstract][Full Text] [Related]
6. The cysteine-cluster motif of c-Yes, Lyn and FAK as a suppressive module for the kinases.
Rahman MA; Senga T; Oo ML; Hasegawa H; Biswas MH; Mon NN; Huang P; Ito S; Yamamoto T; Hamaguchi M
Oncol Rep; 2008 Apr; 19(4):975-80. PubMed ID: 18357384
[TBL] [Abstract][Full Text] [Related]
7. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
8. Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events.
Werdich XQ; Penn JS
Angiogenesis; 2005; 8(4):315-26. PubMed ID: 16400523
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.
Marchetti D; Parikh N; Sudol M; Gallick GE
Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-delta.
Song JS; Swann PG; Szallasi Z; Blank U; Blumberg PM; Rivera J
Oncogene; 1998 Jul; 16(26):3357-68. PubMed ID: 9692543
[TBL] [Abstract][Full Text] [Related]
11. The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endosome requirements.
Sandilands E; Brunton VG; Frame MC
J Cell Sci; 2007 Aug; 120(Pt 15):2555-64. PubMed ID: 17623777
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
[TBL] [Abstract][Full Text] [Related]
13. Rapid trafficking of c-Src, a non-palmitoylated Src-family kinase, between the plasma membrane and late endosomes/lysosomes.
Kasahara K; Nakayama Y; Kihara A; Matsuda D; Ikeda K; Kuga T; Fukumoto Y; Igarashi Y; Yamaguchi N
Exp Cell Res; 2007 Jul; 313(12):2651-66. PubMed ID: 17537435
[TBL] [Abstract][Full Text] [Related]
14. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
Staley CA; Parikh NU; Gallick GE
Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
16. Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES.
Zhang P; Greendorfer JS; Jiao J; Kelpke SC; Thompson JA
Arch Biochem Biophys; 2006 Jun; 450(1):50-62. PubMed ID: 16631103
[TBL] [Abstract][Full Text] [Related]
17. v-Src and c-Src, nonpalmitoylated Src-family kinases, induce perinuclear accumulation of lysosomes through Rab7 in a kinase activity-independent manner.
Kasahara K; Nakayama Y; Yamaguchi N
Cancer Lett; 2008 Apr; 262(1):19-27. PubMed ID: 18171604
[TBL] [Abstract][Full Text] [Related]
18. Expression of C-terminal src kinase in human colorectal cancer cell lines.
Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
[TBL] [Abstract][Full Text] [Related]
19. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.
Summy JM; Qian Y; Jiang BH; Guappone-Koay A; Gatesman A; Shi X; Flynn DC
J Cell Sci; 2003 Jun; 116(Pt 12):2585-98. PubMed ID: 12734402
[TBL] [Abstract][Full Text] [Related]
20. Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor.
Iida M; Brand TM; Campbell DA; Li C; Wheeler DL
Oncogene; 2013 Feb; 32(6):759-67. PubMed ID: 22430206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
